Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort - Concepedia

Concepedia

Publication | Open Access

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

DOI Full Paper Access

196

Citations

19

References

2016

Year

Tania M. Welzel, Jörg Petersen, Kerstin Herzer, Péter Ferenci, Michael Gschwantler, Heiner Wedemeyer, Thomas Berg, Ulrich Spengler, Ola Weiland, Marc van der Valk,

Abstract

NCT02097966.

References

	Year	Citations

Page 1